Heartseed Inc. (TYO:219A)

Japan flag Japan · Delayed Price · Currency is JPY
2,333.00
-37.00 (-1.56%)
May 14, 2025, 12:45 PM JST
50.71%
Market Cap 52.20B
Revenue (ttm) 873.61M
Net Income (ttm) -812.73M
Shares Out 22.35M
EPS (ttm) -49.43
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 302,500
Average Volume 985,630
Open 2,370.00
Previous Close 2,370.00
Day's Range 2,289.00 - 2,370.00
52-Week Range 901.00 - 3,880.00
Beta n/a
RSI 52.34
Earnings Date Jun 12, 2025

About Heartseed

Heartseed Inc. develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure. The company’s lead product candidate is HS-001 for heart failure with reduced ejection fraction indications, including dilated cardiomyopathy, old myocardial infraction, and dilated phase of hypertrophic cardiomyopathy. It also develops products using autologous iPSC and HLA knock-out iPSC. The company was incorporated in 2015 and is headquartered in Tokyo, Japan. [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 2015
Country Japan
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 219A
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.